Unveiling the Anti-Inflammatory Potential of Urena lobata: Insights into Nitric Oxide Suppression and Protein Targets
Trends in Sciences · 25.03.2026 · 23 (9) · 12876
DOI: 10.48048/tis.2026.12876 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trends in Sciences, online erschienen am 25.03.2026. Verfasst von Yudi Purnomo und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Urena lobata is recognized for its traditional medicinal use, particularly in addressing inflammation-related ailments. This study examined the anti-inflammatory properties of U. lobata extract and its fractions, focusing on their ability to suppress nitric oxide (NO) synthesis, a key mediator of inflammation. In vitro experiments using LPS-stimulated RAW 264.7 macrophages showed that the crude extract of U. lobata had an IC50 of 58.05 ± 5.87 µg/mL, while the ethyl acetate fraction showed greater suppression of NO formation with an IC50 of 31.40 ± 10.56 µg/mL. On the other hand, the n-butanol fraction and the water-soluble fraction did not have a significant effect on inhibition. Toxicity tests also showed that the n-hexane fraction was good at reducing NO formation (IC50 of 49.73 ± 9.49 µg/mL), but was toxic to cells at higher concentrations (> 200 µg/mL). The ethyl acetate fraction also inhibited the formation of important pro-inflammatory mediators, such as inducible nitric oxide synthase (iNOS), interleukin (IL)-12, and tumor necrosis factor-alpha (TNF-α). Protein target analysis revealed 40 proteins associated with the inflammatory cascade as potential targets for active chemicals in U. lobata. Molecular docking studies identified quercetin, apigenin, and luteolin as key bioactive compounds with strong binding affinity for inflammation-related proteins such as AKR1B1, NOX4, and CDK5, which subsequently influence NO suppression during inflammation, suggesting a multi-target mechanism of action. These results emphasize the therapeutic potential of U. lobata and its bioactive chemicals as candidates for natural anti-inflammatory drug formulations, while also underscoring the need to evaluate potential cytotoxicity in future studies. HIGHLIGHTS Urena lobata extract and its ethyl acetate fraction significantly inhibited nitric oxide (NO) production in LPS-stimulated RAW 264.7 macrophages. Compared with other fractions, the ethyl acetate fraction exhibited superior anti-inflammatory activity (IC₅₀: 31.40 ± 10.56 µg/mL). The ethyl acetate fraction successfully downregulated key pro-inflammatory mediators, including TNF-α, IL-12, and iNOS. Using molecular docking, quercetin, apigenin, and luteolin were identified as key bioactive compounds targeting inflammation-related proteins (AKR1B1, NOX4, and CDK5). The multitarget mechanism underlying the anti-inflammatory effects of lobata was demonstrated by the prediction of 40 inflammation-related protein targets. GRAPHICAL ABSTRACT
Zitieren
APA
Purnomo, Y., Tilaqza, A., Wahyuningsih, D., & Dwijayanti, D. R. (2026). Unveiling the Anti-Inflammatory Potential of Urena lobata: Insights into Nitric Oxide Suppression and Protein Targets. Trends in Sciences, 23(9), 12876. https://doi.org/10.48048/tis.2026.12876
Vancouver
Purnomo Y, Tilaqza A, Wahyuningsih D, Dwijayanti DR. Unveiling the Anti-Inflammatory Potential of Urena lobata: Insights into Nitric Oxide Suppression and Protein Targets. Trends in Sciences. 2026;23(9):12876. doi:10.48048/tis.2026.12876
BibTeX
@article{Purnomo2026,
author = {Purnomo, Yudi and Tilaqza, Andri and Wahyuningsih, Doti and Dwijayanti, Dinia Rizqi},
title = {Unveiling the Anti-Inflammatory Potential of Urena lobata: Insights into Nitric Oxide Suppression and Protein Targets},
journal = {Trends in Sciences},
year = {2026},
volume = {23},
number = {9},
pages = {12876},
doi = {10.48048/tis.2026.12876}
}
EUVIMED